{"id":"16cb36ce-206a-48bc-a913-4c830425be32","kind":"news","code":"16cb36ce-206a-48bc-a913-4c830425be32","name":"Panpuluona completes Pre-Series A financing","nameBasis":"translated-title","summary":"On 2026-08-21, according to Xiniu Data, Panpuluona completed Pre-Series A financing for an undisclosed amount. Investors were Hubei Changjiangketouyuanchuangliqingyuanlian Venture Capital Partnership (Limited Partnership). The company is an AI-driven developer of innovative targeted protein degradation drugs.","description":"","country":null,"category":null,"originalName":"潘普洛纳完成Pre-A轮融资","eventDate":"2026-08-21T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T05:58:27.805Z","englishUpdatedAt":"2026-10-20T18:23:32.073Z","reviewedAt":"2026-10-20T18:23:32.073Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"6db77ea10494eac289ae6004f841e8f163d77cb48c357a5b181151f5cc8c8138","companyId":"f73ce274-c98f-484d-b361-8643f93b10f7","foundedYear":null,"logoUrl":null,"originalText":"2026年8月21日，据烯牛数据报道，潘普洛纳完成Pre-A轮融资，金额未披露。投资方为湖北长江科投源创力清源离岸创业投资合伙企业（有限合伙）。该公司为AI驱动靶向蛋白降解创新药研发商。","sources":[],"related":[{"id":"91494d62-6e49-408f-9f2f-52e6f2f49933","kind":"institutions","code":"UB-I7165","name":"Hubei Changjiangketouyuanchuangliqingyuanlian Venture Capital Partnership (Limited Partnership)","nameBasis":"transliterated","summary":"Hubei Changjiangketouyuanchuangliqingyuanlian Venture Capital Partnership (Limited Partnership), a government-backed industrial investment guidance fund.","description":"Hubei Changjiangketouyuanchuangliqingyuanlian Venture Capital Partnership (Limited Partnership), a government-backed industrial investment guidance fund.","country":null,"category":null,"originalName":"湖北长江科投源创力清源离岸创业投资合伙企业（有限合伙）","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T20:00:13.242Z","englishUpdatedAt":"2026-10-16T01:39:37.829Z","reviewedAt":"2026-10-16T01:39:37.829Z","snapshotAt":"2026-10-16T01:37:59.763Z","sourceHash":"141b2fc5b44690acc1f34c6805d2250414bc5e4b552857e8b5105d1cb6ff12e4","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/hubei-changjiangketouyuanchuangliqingyuanlian-venture-capital-partnership-limited-partnership"},{"id":"f73ce274-c98f-484d-b361-8643f93b10f7","kind":"companies","code":"UB-C9945","name":"Panpuluona","nameBasis":"transliterated","summary":"AI-driven developer of innovative targeted protein degradation drugs.","description":"AI-driven developer of innovative targeted protein degradation drugs.","country":"China","category":null,"originalName":"潘普洛纳","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-14T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:26:43.043Z","reviewedAt":"2026-10-20T18:26:43.043Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"13a96b2b0d68f57ae0f41b7c469c92527ddb1e883b0e933486ce6558d3b48e35","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C9945"}],"path":"/news/16cb36ce-206a-48bc-a913-4c830425be32","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Panpuluona","path":"/companies/UB-C9945"}},"canonical":"https://uniquebase.ai/news/16cb36ce-206a-48bc-a913-4c830425be32"}